Nateglinide and blood sodium decreased Patient Reports February 10, 2010
Nateglinide Side Effects Report #5602160-3
Nateglinide side effect was reported by a Physician from SPAIN on Jan 16, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: blood sodium decreased, electrolyte imbalance. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.
Nateglinide Side Effects Report #5611241-X
Nateglinide side effect was reported by a Physician from SPAIN on Jan 23, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: blood sodium decreased, electrolyte imbalance. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.
Nateglinide Side Effects Report #5669714-X
Nateglinide side effect was reported by a Physician from SPAIN on Mar 05, 2008. Male patient, 88 years of age, weighting 130.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: asthenia, blood potassium increased, blood sodium decreased, electrolyte imbalance, gait disturbance, hyponatraemia, polyuria, vomiting. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.
Nateglinide Side Effects Report #5445885-5
Nateglinide side effect was reported by a Health Professional from JAPAN on Aug 30, 2007. Male patient, 61 years of age, was diagnosed with diabetes mellitus and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: altered state of consciousness, bladder irrigation, blood albumin decreased, blood creatinine decreased, blood potassium decreased, blood sodium decreased, body mass index decreased, decreased appetite, diarrhoea. Nateglinide dosage: 270 MG QD. During the same period patient was treated with GLUCOBAY, MELBIN, FAMOTIDINE, ALDACTONE, LASIX, METHYCOBAL. Patient was hospitalized. Patient recovered.
Nateglinide and blood sodium decreased 